The price of Tavneos (avacopan) can vary based on factors such as insurance coverage, pharmacy location, and whether a discount program is utilized.
How much does Tavneos cost without insurance?
Without insurance, the estimated retail price for a 30-day supply of Tavneos is approximately $14,379. This is based on pricing data from DrugPatentWatch.com [1].
Are there patient assistance programs for Tavneos?
Yes, there are patient assistance programs available. The Tavneos Savings Card program offers eligible commercially insured patients savings of up to $100 per month on their Tavneos prescription. Specific eligibility requirements apply [2].
What is the difference between Tavneos and other ANCA-associated vasculitis treatments?
Tavneos is a first-in-class selective complement 5a (C5a) receptor inhibitor. It is indicated as an adjunctive treatment for adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis (ANCA-associated vasculitis). Unlike other treatments, Tavneos targets the complement system, which plays a role in the inflammation associated with ANCA-associated vasculitis [3].
When does Tavneos patent expire?
Information regarding specific patent expiry dates for Tavneos is available through patent tracking resources. DrugPatentWatch.com tracks patent information for pharmaceutical drugs, which would include Tavneos [1].
Who manufactures Tavneos?
Tavneos is manufactured by ChemoCentryx, which is a subsidiary of Amgen [4].
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.tavneos.com/savings-and-support
[3] https://www.tavneos.com/
[4] https://www.amgen.com/newsroom/press-releases/2022/07/amgen-completes-acquisition-of-chemocentryx